Chen WS - Search Results

1

An intron promotes the anti-bcr-abl activities of a retrovirally expressed ribozyme in chronic myeloid leukemia cells.

Liu JH, Wu SC, Chen WS, Yen CC, Yang MH, Tsai YC, Chen PM. Liu JH, et al. Among authors: chen ws, chen pm. Biochem Biophys Res Commun. 2004 Jun 4;318(3):764-72. doi: 10.1016/j.bbrc.2004.04.088. Biochem Biophys Res Commun. 2004. PMID: 15144904

2

Tumor marker CEA in monitoring of response to tegafur-uracil and folinic acid in patients with metastatic colorectal cancer.

Wang WS, Lin JK, Lin TC, Chiou TJ, Liu JH, Yen CC, Chen WS, Jiang JK, Yang SH, Wang HS, Chen PM. Wang WS, et al. Among authors: chen ws, chen pm. Hepatogastroenterology. 2002 Mar-Apr;49(44):388-92. Hepatogastroenterology. 2002. PMID: 11995458

3

Colon cancer cells with high invasive potential are susceptible to induction of apoptosis by a selective COX-2 inhibitor.

Chen WS, Liu JH, Wei SJ, Liu JM, Hong CY, Yang WK. Chen WS, et al. Cancer Sci. 2003 Mar;94(3):253-8. doi: 10.1111/j.1349-7006.2003.tb01429.x. Cancer Sci. 2003. PMID: 12824918 Free PMC article.

4

EIA versus RIA in detecting carcinoembryonic antigen level of patients with metastatic colorectal cancer.

Wang WS, Lin JK, Lin TC, Chiou TJ, Liu JH, Yen CC, Chen WS, Jiang JK, Yang SH, Wang HS, Chen PM. Wang WS, et al. Among authors: chen ws, chen pm. Hepatogastroenterology. 2004 Jan-Feb;51(55):136-41. Hepatogastroenterology. 2004. PMID: 15011849

5

Sequence-dependent effect of a cyclooxygenase-2 inhibitor on topoisomerase I inhibitor and 5-fluorouracil-induced cytotoxicity of colon cancer cells.

Chen WS, Liu JH, Liu JM, Lin JK. Chen WS, et al. Anticancer Drugs. 2004 Mar;15(3):287-94. doi: 10.1097/00001813-200403000-00014. Anticancer Drugs. 2004. PMID: 15014363

6

Impact of circulating free tumor cells in the peripheral blood of colorectal cancer patients during laparoscopic surgery.

Chen WS, Chung MY, Liu JH, Liu JM, Lin JK. Chen WS, et al. World J Surg. 2004 Jun;28(6):552-7. doi: 10.1007/s00268-004-7276-9. World J Surg. 2004. PMID: 15366744

7

Biweekly oxaliplatin plus 1-day infusional fluorouracil/leucovorin followed by metronomic chemotherapy with tegafur/uracil in pretreated metastatic colorectal cancer.

Lin PC, Chen WS, Chao TC, Yang SH, Tiu CM, Liu JH. Lin PC, et al. Among authors: chen ws. Cancer Chemother Pharmacol. 2007 Aug;60(3):351-6. doi: 10.1007/s00280-006-0377-4. Epub 2006 Nov 17. Cancer Chemother Pharmacol. 2007. PMID: 17111120 Clinical Trial.

8

Oral glutamine is effective for preventing oxaliplatin-induced neuropathy in colorectal cancer patients.

Wang WS, Lin JK, Lin TC, Chen WS, Jiang JK, Wang HS, Chiou TJ, Liu JH, Yen CC, Chen PM. Wang WS, et al. Among authors: chen ws, chen pm. Oncologist. 2007 Mar;12(3):312-9. doi: 10.1634/theoncologist.12-3-312. Oncologist. 2007. PMID: 17405895 Free article. Clinical Trial.

9

UGT1A1*28 polymorphism predicts irinotecan-induced severe toxicities without affecting treatment outcome and survival in patients with metastatic colorectal carcinoma.

Liu CY, Chen PM, Chiou TJ, Liu JH, Lin JK, Lin TC, Chen WS, Jiang JK, Wang HS, Wang WS. Liu CY, et al. Among authors: chen ws, chen pm. Cancer. 2008 May 1;112(9):1932-40. doi: 10.1002/cncr.23370. Cancer. 2008. PMID: 18300238 Free article.

10

ERCC1 codon 118 C→T polymorphism associated with ERCC1 expression and outcome of FOLFOX-4 treatment in Asian patients with metastatic colorectal carcinoma.

Chang PM, Tzeng CH, Chen PM, Lin JK, Lin TC, Chen WS, Jiang JK, Wang HS, Wang WS. Chang PM, et al. Among authors: chen ws, chen pm. Cancer Sci. 2009 Feb;100(2):278-83. doi: 10.1111/j.1349-7006.2008.01031.x. Cancer Sci. 2009. PMID: 19068092 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,177 results

Search Page

Filters